Received Apr 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
2 years of age received 2/3 of an Infanrix vaccine, this situation happened 22-Apr-2025; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete dose administered in a 2-year-old male patient who received DTPa (Infanrix) for prophylaxis. On 22-APR-2025, the patient received Infanrix. On 22-APR-2025, an unknown time after receiving Infanrix, the patient experienced incomplete dose administered (Verbatim: 2 years of age received 2/3 of an Infanrix vaccine, this situation happened 22-Apr-2025). The outcome of the incomplete dose administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 22-APR-2025 Practice manager called and reported that patient received 2o/3 of an Infanrix vaccine, this situation happened on the day of reporting, which led to incomplete dose administered. The vaccine administration facility was the same as primary reporter. The reporter did not have the lot number nor expiry date of the vaccine. During the call, the reporter mentioned the vaccine as Boostrix, and then, she mentioned that actually it was the DTap Infanrix vaccine.